Insights Into Mineralys Therapeutics's Upcoming Earnings
Insights Into Mineralys Therapeutics's Upcoming Earnings
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Mineralys Therapeutics (NASDAQ:MLYS) is set to give its latest quarterly earnings report on Monday, 2024-11-11. Here's what investors need to know before the announcement.
Mineralys Therapeutics（纳斯达克：MLYS）定于2024年11月11日（星期一）公布最新季度财报。投资者在公布之前需要了解的内容如下。
Analysts estimate that Mineralys Therapeutics will report an earnings per share (EPS) of $-0.83.
分析师预计Mineralys Therapeutics将报告每股收益（EPS）为-0.83美元。
Anticipation surrounds Mineralys Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
投资者对Mineralys Therapeutics的公告充满期待，希望听到超过预期的消息，并获得下一季度的积极指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投资者应该了解，尽管收益表现很重要，但市场反应往往受到指引的推动。
Earnings History Snapshot
收益历史快照
Last quarter the company missed EPS by $0.13, which was followed by a 22.82% drop in the share price the next day.
上一季度，该公司的每股收益低于0.13美元，随后股价第二天下跌了22.82%。
Here's a look at Mineralys Therapeutics's past performance and the resulting price change:
让我们来看看Mineralys Therapeutics过去的表现和随之而来的价格变化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.67 | -0.82 | -0.76 |
| EPS Actual | -0.83 | -0.70 | -0.61 | -0.57 |
| Price Change % | -23.0% | -5.0% | -2.0% | -7.000000000000001% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益预估值 | -0.70 | -0.67 | -0.82 | -0.76 |
| 每股收益实际值 | -0.83 | -0.70 | -0.61 | -0.57 |
| 价格变更% | -23.0% | -5.0% | -2.0% | -7.000000000000001% |
Performance of Mineralys Therapeutics Shares
Mineralys Therapeutics股票表现
Shares of Mineralys Therapeutics were trading at $14.16 as of November 07. Over the last 52-week period, shares are up 124.06%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
截至11月7日，Mineralys Therapeutics股票交易价格为$14.16。在过去的52周内，股价上涨了124.06%。考虑到这些回报通常是积极的，长期股东可能会看好这一财报发布。
To track all earnings releases for Mineralys Therapeutics visit their earnings calendar on our site.
要追踪Mineralys Therapeutics所有财报，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
